ML-SYS / 2026.07NON-CLINICAL RESEARCH MATERIALSORIGIN DECLARED BY LOT

← Current products

ML-NAD+ / RM-MCE

NAD+

A ubiquitous redox cofactor. Direct intravenous human research is limited in scope.

This item is currently available. Pricing and the supply term are confirmed in the written response.

Evidence position

Human evidenceEvidence grade B: Human evidence

Grade B, with prominent limitations. The available human work is pharmacokinetic and metabolic, not broad efficacy. No energy, anti-ageing or disease claim is supportable.

Full reference entry

Documents

Lot
Assigned at fulfilment
Origin
Confirmed with the lot record
Analytical record
Lot-linked documentation is confirmed with the written response.